Go to content
Logo Medicines Authority MEB
You are here: Home
  • Medicines Information Bank
  • Veterinary Medicines Information Bank

Main menu

  • Marketing authorisation medicines for human use

    Procedures, dossier requirements, pharmacovigilance, policy

  • Veterinary Medicinal Products Unit

    Marketing authorisation, reporting adverse events, production, distribution

  • About MEB

    Our story, our work, the organisation, working at the MEB, contact

Home

News

Changes to fees for human medicinal products and devices as of 1 January 2023

02-01-2023 | 08:00

With effect from 1 January 2023, the Medicines Evaluation Board (MEB) will be increasing the fees for authorisation applications, ...

Registering the continued use of antimycotics or antiprotozoal veterinary medicinal products exclusively intended for specific companion animals

29-12-2022 | 12:15

Prior to the introduction of theĀ  Veterinary Medicinal Products Regulation, antimycotics (antifungal agents) and antiprotozoal ...

Veterinary Medicinal Products Unit Fees for 2023 in revised Veterinary Medicinal Products Regulation 2022

29-12-2022 | 12:00

With effect from 1 January 2023, the Medicines Evaluation Board (MEB) will be increasing the fees. The fees of the Veterinary ...

New issue of Regulatory Science Magazine

07-12-2022 | 14:15

A significant portion of the potential anticancer medicines that reach the clinical phase do not make it to registration. This is ...

Amended procedure for sending, communicating and publishing letters and decisions

06-10-2022 | 16:30

The Veterinary Medicinal Products Unit has set in motion a number of changes to the sending, communicating and publishing letters ...

Form for specifying an e-mail address for receipt of digital decisions

16-08-2022 | 10:00

As from 1 October, the Veterinary Medicinal Products Unit will no longer send marketing authorisations in hard copy. We ask all ...

More news
ISO 9001:2015
Good medicines used better.

Service

  • Contact
  • Working at the MEB
  • Sitemap
  • Help
  • Archive
  • Subscribe

About this site

  • Copyright
  • Privacy
  • Cookies
  • Accessibility
  • Report vulnerability

This website in other languages:

  • Nederlands